Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Chronic Disease Sufferers To Benefit From New ‘At Home’ Diagnostic Device

22.07.2004


People who suffer from chronic diseases, including high blood pressure, diabetes, asthma and heart problems should benefit from a new remote, home care monitoring system that could also bring an end to overcrowded waiting rooms.



With project partners in Estonia, Latvia and the UK facing research costs of over €2 million, the development of Doc@HOME® was made possible with the help of a grant of €1.1 million from the Information Society Technology (IST) Programme of the European Union’s Framework Programme. It is now set to improve the quality of life of thousands of people, including the elderly and disabled, by freeing up time currently spent on doctors and hospital visits. This in turn will help ease the pressure on the family doctor.

Low cost and easy to use, Doc@HOME® gives the patient a sense of control over their condition and allows their medical carers to stay ahead of the disease. It also provides education about the disease and its risk factors, and supports lifestyle modification strategies that need to be introduced to help manage the condition.


Adrian Flowerday, managing director of the UK partner Docobo UK, is confident the new system will be welcomed around the world, saying: "The World Health Organisation sees Chronic Disease as being the greatest challenge to the healthcare systems and populations of the world this century. The Doc@HOME® service provides a low cost, home based chronic disease management solution to help the national healthcare organisations address these challenges. Patients with chronic diseases such as hypertension, Chronic Obstructive Pulmonary Disease (COPD) and diabetes will be enabled to monitor and control their own condition, confident in the knowledge that the healthcare systems are monitoring their progress."

Peter Walters, UK National Contact Point for IST within the EU’s 6th Framework Programme, believes that the Doc@HOME® project is a prime example of the major contribution EU funding has in the development of information and communications technology: “This project shows how, with the right financial support, information technology can have a much wider role to play in our futures. Without support from the EU’s Framework Programme this project may not have been possible.”

“The Framework Programmes are the EU’s main vehicle for support of leading edge, internationally collaborative R&D. The current Framework Programme (FP6) runs until 2006 and organisations wanting free information on how to access some of the €17.5bn available should log on to http://fp6uk.ost.gov.uk or call central telephone support on 0870 600 6080.”

With over two billion people in the world suffering with Hypertension and Diabetes, conservative forecasts indicate that Doc@HOME® will have around 300,000 users by 2007. Potential customers for the system include both public and private healthcare organisations, health conscious consumers, insurance companies and occupational health departments within large employers, and the manufacturers have already identified a potential sales revenue of £70 million.

The system is being trailed with two NHS organisations and patients involved in the trials are pleased with the service. “I would like to control my blood pressure without having to become dependant upon medication,” says businessman Ian MacDonald of Glasgow. “The Doc@HOME® service helped me to appreciate and control my blood pressure. I had to travel a lot during the period of the trial and this handy, portable unit made it easy to monitor my blood pressure and adjust my lifestyle accordingly. Anything that enables people to have better control of their health must be a good thing.”

Fellow patient John Millar, also from Glasgow, added: “It will be particularly helpful to people just starting on medication as it also reminds you when to take it. I would also recommend it to my doctor as I believe that any system that helps reduce the pressure on him has got to be a great concept.”

The device includes basic ECG capability for arrhythmia and the detection of other long terms trends. It can also integrate with other pieces of medical equipment – blood pressure, weight, glucose measuring devices etc - to collect, store and forward the entered data.

Already the system is being adapted for patients who need regular monitoring for a number of medical conditions, including: Chronic Heart Failure (CHF), Asthma, Diabetes, Post-Stroke care and surveillance, Chronic Obstructive Pulmonary Disease, Chronic respiratory disease.

The system is also expandable to more general interest groups like weight control and personal fitness programs, and reduces the overall cost of patient care, bringing a rage of benefits to the patient, their family and their doctor.

Patient benefits include:

A more active role in the health support process.
More control over the symptoms of illness and therefore more freedom of life.
Improved chances to continue regular working by freeing up the time spent on regular visits to medical institutions.
The sense of care immediacy.

Benefits to the doctor include:

A continuous and adequate overview of the health status of the patient in their actual living environment.
Easier management of a large number of patients.
A reduction of the misplaced time and expenditures.

Family members also benefit by having a better overview of the health status of their relative, and the pressure on hospitals will be eased thanks to a reduction of admissions of patients with chronic conditions for routine examination.

The system is built around a low-cost device (the projected end user cost is around 200 Euros) specially constructed for the purpose of long-term trouble free data collection, with design features considering the needs of the typical home care population (elderly people, disabled people etc).

Dave Sanders | alfa
Further information:
http://www.glasgows.co.uk

More articles from Health and Medicine:

nachricht A better way to measure the stiffness of cancer cells
01.03.2017 | Duke University

nachricht Humans have three times more brown body fat
01.03.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

Im Focus: Safe glide at total engine failure with ELA-inside

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded after a glide flight with an Airbus A320 in ditching on the Hudson River. All 155 people on board were saved.

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded...

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

A better way to measure the stiffness of cancer cells

01.03.2017 | Health and Medicine

Exploring the mysteries of supercooled water

01.03.2017 | Physics and Astronomy

Research team of the HAW Hamburg reanimated ancestral microbe from the depth of the earth

01.03.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>